Elmiron Connected to Retinal Damage
In a study presented to members of the American Academy of Opthalmology, the drug, Elmiron (Pentosan Polysulfate Sodium) was shown to cause pigmentary maculopathy in about 25% of the patients who take it.
The retinal damage includes
- pigmentary maculopathy,
- dark spots on the retina,
- difficulty reading,
- difficulty adjusting to dim light
- impaired vision.
Elmiron is one of the only FDA-approved drugs for treatment of painful bladder syndrome, so many patients take this medication for years, seeking relief.
Elmiron is commonly prescribed for interstitial cystitis – painful bladder syndrome – a condition that results in chronic pain, for which there is no cure. The more doses and years that a patient has taken Elmiron, the more likely that pigmentary maculopathy will develop.
What should you do?
Please contact Davis & Crump if you or a loved one has taken Elmiron (Pentosan Polysulfate Sodium) for at least a year and have been diagnosed with pigmentary maculopathy. Call Davis & Crump for a free claim evaluation. We are experienced in defective drug litigations and settlements. Consult with us today about your potential claim without cost or obligation. Our firm advances all costs associated with your case, so there is no fee unless we make a successful recovery for you. With over 70 years of combined experience, our firm pursues a successful conclusion to each and every case.
Fill out a free claim evaluation or call us at 1-800-277-0300 to get started.